Variable | Number |
---|---|
Median age (year) | 6 |
Range | 0.5-16 |
Gender | |
Male | 20 |
Female | 9 |
Underlying disease | |
Malignant: | |
AML | 5 |
ALL | 4 |
MDS | 3 |
JMML | 1 |
Burkitt lymphoma | 1 |
CML | 1 |
Non-malignant: | |
AA | 8 |
PID-SCI D | 5 |
PID-non-SCID | 1 |
Transplant type: | |
Related | 11 |
Unrelated | 18 |
aGVHD(I-IV) | |
0-I | 20 |
II-IV | 9 |
cGVHD | 0 |
Preprocessing scheme | |
Myeloablative | 18 |
Non-myeloablative | 9 |
No | 2 |
Median time of duration pre-transplant (month) | 9 |
Range | 1-37 |
Median time of duration after completed transplantation (day) | 74 |
Range | 2-540 |